Physician profile
Aaron Storm
NPI 1891237350
$2,970.80
in general payments reported to CMS, 2019-2025
16 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $605 · 2023: $452 · 2024: $1,400 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,834 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.91 |
| Travel and Lodging | $337.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,041.30 | 2022-2024 | Symplicity G3 |
| Abbott Laboratories | $976.37 | 2022-2025 | Cardiomems, Ultreon, Mitraclip |
| Amgen INC. | $287.03 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $174.89 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.50 | 2021-2022 | |
| Pfizer INC. | $64.97 | 2024-2025 | |
| Edwards Lifesciences Corporation | $64.91 | 2021 | |
| Abiomed | $62.88 | 2023-2024 | Impella |
| Impulse Dynamics (USA) INC. | $55.29 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $29.37 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $29.18 | 2024 | Arcalyst |
| United Therapeutics Corporation | $28.69 | 2025 | Tyvaso |
| Boston Scientific Corporation | $27.76 | 2022 | |
| Cvrx, INC. | $25.81 | 2023-2024 | Barostim Neo System |
| Chiesi USA, INC. | $14.85 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Storm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.